candesartan cilexetil has been researched along with Liver Cirrhosis in 2 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In conclusion, progression of liver fibrosis reduces AGTR1 expression." | 1.34 | Expression of angiotensin II receptor type 1 is reduced in advanced rat liver fibrosis. ( Daudi, SM; Goeser, T; Kern, MA; Klanac, D; Kociok, N; Laue, O; Scheller, I; Schirmacher, P; Schulte, S; Steffen, HM; Töx, U, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Töx, U | 1 |
| Scheller, I | 1 |
| Kociok, N | 1 |
| Kern, MA | 1 |
| Klanac, D | 1 |
| Daudi, SM | 1 |
| Laue, O | 1 |
| Schirmacher, P | 1 |
| Goeser, T | 1 |
| Schulte, S | 1 |
| Steffen, HM | 1 |
| Kitamura, K | 1 |
| Tada, S | 1 |
| Nakamoto, N | 1 |
| Toda, K | 1 |
| Horikawa, H | 1 |
| Kurita, S | 1 |
| Tsunematsu, S | 1 |
| Kumagai, N | 1 |
| Ishii, H | 1 |
| Saito, H | 1 |
| Hibi, T | 1 |
2 other studies available for candesartan cilexetil and Liver Cirrhosis
| Article | Year |
|---|---|
Expression of angiotensin II receptor type 1 is reduced in advanced rat liver fibrosis.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Collagen Type I; Disease Progression; Liver; Liver Cirr | 2007 |
Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Topics: Alanine Transaminase; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aspa | 2007 |